<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-pathogens-08-00176">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gragnani</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Visentini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fognani</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Urraro</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>De Santis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Petraccia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Perez</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ceccotti</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Colantuono</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mitrevski</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia</article-title>
  <source>Hepatology</source>
  <year>2016</year>
  <volume>64</volume>
  <fpage>1473</fpage>
  <lpage>1482</lpage>
  <pub-id pub-id-type="doi">10.1002/hep.28753</pub-id>
  <pub-id pub-id-type="pmid">27483451</pub-id>
 </element-citation>
</ref>
